Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 25 studies | 37% ± 16% | |
vein endothelial cell | 14 studies | 43% ± 19% | |
endothelial cell of artery | 12 studies | 44% ± 22% | |
fibroblast | 11 studies | 27% ± 12% | |
endothelial cell of vascular tree | 10 studies | 27% ± 10% | |
endothelial cell of lymphatic vessel | 8 studies | 25% ± 7% | |
basal cell | 8 studies | 35% ± 9% | |
astrocyte | 5 studies | 30% ± 12% | |
capillary endothelial cell | 4 studies | 35% ± 23% | |
retinal pigment epithelial cell | 4 studies | 22% ± 2% | |
endothelial cell of sinusoid | 4 studies | 38% ± 14% |
Insufficient scRNA-seq data for expression of IL33 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 2702.64 | 240 / 245 | 93% | 20.67 | 468 / 502 |
lung | 99% | 3184.81 | 572 / 578 | 83% | 27.73 | 956 / 1155 |
stomach | 100% | 3338.60 | 358 / 359 | 77% | 31.70 | 219 / 286 |
intestine | 86% | 2306.61 | 826 / 966 | 82% | 38.75 | 434 / 527 |
brain | 71% | 908.47 | 1866 / 2642 | 97% | 43.78 | 683 / 705 |
uterus | 99% | 3148.88 | 169 / 170 | 57% | 23.58 | 261 / 459 |
bladder | 100% | 4592.57 | 21 / 21 | 56% | 24.70 | 283 / 504 |
breast | 98% | 2890.54 | 449 / 459 | 57% | 13.12 | 636 / 1118 |
thymus | 96% | 1743.74 | 628 / 653 | 57% | 6.80 | 343 / 605 |
adrenal gland | 97% | 1525.69 | 249 / 258 | 56% | 7.56 | 128 / 230 |
esophagus | 96% | 3923.16 | 1380 / 1445 | 54% | 13.04 | 98 / 183 |
skin | 66% | 1132.51 | 1190 / 1809 | 53% | 13.55 | 249 / 472 |
blood vessel | 99% | 3973.87 | 1324 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 3635.02 | 1186 / 1204 | 0% | 0 | 0 / 0 |
liver | 50% | 600.71 | 112 / 226 | 42% | 7.28 | 172 / 406 |
kidney | 29% | 289.09 | 26 / 89 | 62% | 11.69 | 561 / 901 |
heart | 91% | 2434.80 | 786 / 861 | 0% | 0 | 0 / 0 |
pancreas | 8% | 71.65 | 27 / 328 | 78% | 17.57 | 138 / 178 |
lymph node | 0% | 0 | 0 / 0 | 79% | 16.07 | 23 / 29 |
tonsil | 0% | 0 | 0 / 0 | 60% | 12.35 | 27 / 45 |
spleen | 56% | 505.61 | 135 / 241 | 0% | 0 | 0 / 0 |
ovary | 30% | 484.83 | 54 / 180 | 21% | 2.65 | 89 / 430 |
muscle | 15% | 122.25 | 122 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.60 | 4 / 80 |
peripheral blood | 0% | 4.89 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0002826 | Biological process | negative regulation of T-helper 1 type immune response |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0150142 | Biological process | positive regulation of CD86 production |
GO_0042092 | Biological process | type 2 immune response |
GO_0120042 | Biological process | negative regulation of macrophage proliferation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0002686 | Biological process | negative regulation of leukocyte migration |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0045348 | Biological process | positive regulation of MHC class II biosynthetic process |
GO_0051770 | Biological process | positive regulation of nitric-oxide synthase biosynthetic process |
GO_0061518 | Biological process | microglial cell proliferation |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0030225 | Biological process | macrophage differentiation |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0051607 | Biological process | defense response to virus |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0010186 | Biological process | positive regulation of cellular defense response |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0038172 | Biological process | interleukin-33-mediated signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045345 | Biological process | positive regulation of MHC class I biosynthetic process |
GO_0043032 | Biological process | positive regulation of macrophage activation |
GO_0002638 | Biological process | negative regulation of immunoglobulin production |
GO_0032754 | Biological process | positive regulation of interleukin-5 production |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_0006606 | Biological process | protein import into nucleus |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0010467 | Biological process | gene expression |
GO_0150078 | Biological process | positive regulation of neuroinflammatory response |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0106015 | Biological process | negative regulation of inflammatory response to wounding |
GO_0150145 | Biological process | positive regulation of CD80 production |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0002282 | Biological process | microglial cell activation involved in immune response |
GO_0002830 | Biological process | positive regulation of type 2 immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0030133 | Cellular component | transport vesicle |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0002112 | Molecular function | interleukin-33 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL33 |
Protein name | Interleukin-33 (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Cleaved into: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)] Alternative protein IL33 Interleukin-33 |
Synonyms | C9orf26 IL1F11 NFHEV |
Description | FUNCTION: Cytokine that binds to and signals through the IL1RL1/ST2 receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells . Involved in the maturation of Th2 cells inducing the secretion of T-helper type 2-associated cytokines . Also involved in activation of mast cells, basophils, eosinophils and natural killer cells . Acts as an enhancer of polarization of alternatively activated macrophages . Acts as a chemoattractant for Th2 cells, and may function as an 'alarmin', that amplifies immune responses during tissue injury . Induces rapid UCP2-dependent mitochondrial rewiring that attenuates the generation of reactive oxygen species and preserves the integrity of Krebs cycle required for persistent production of itaconate and subsequent GATA3-dependent differentiation of inflammation-resolving alternatively activated macrophages (By similarity). .; FUNCTION: In quiescent endothelia the uncleaved form is constitutively and abundantly expressed, and acts as a chromatin-associated nuclear factor with transcriptional repressor properties, it may sequester nuclear NF-kappaB/RELA, lowering expression of its targets . This form is rapidely lost upon angiogenic or pro-inflammatory activation . . |
Accessions | ENST00000456383.3 [O95760-2] ENST00000611532.4 [O95760-3] A0A1I9RI50 A0A1I9RI51 ENST00000381434.7 [O95760-1] L8ECM0 ENST00000682010.1 [O95760-1] ENST00000417746.6 [O95760-4] O95760 |